ID   CSK2B_HUMAN             Reviewed;         215 AA.
AC   P67870; B0UXA9; P07312; P13862; Q4VX47;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Casein kinase II subunit beta;
DE            Short=CK II beta;
DE   AltName: Full=Phosvitin;
DE   AltName: Full=Protein G5a;
GN   Name=CSNK2B; Synonyms=CK2N, G5A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2666134; DOI=10.1111/j.1432-1033.1989.tb14917.x;
RA   Jakobi R., Voss H., Pyerin W.;
RT   "Human phosvitin/casein kinase type II. Molecular cloning and
RT   sequencing of full-length cDNA encoding subunit beta.";
RL   Eur. J. Biochem. 183:227-233(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1694965; DOI=10.1016/0921-8777(90)90036-5;
RA   Teitz T., Eli D., Penner M., Bakhanashvili M., Naiman T., Timme T.L.,
RA   Wood C.M., Moses R.E., Canaani D.;
RT   "Expression of the cDNA for the beta subunit of human casein kinase II
RT   confers partial UV resistance on xeroderma pigmentosum cells.";
RL   Mutat. Res. 236:85-97(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2513884; DOI=10.1021/bi00449a014;
RA   Heller-Harrison R.A., Meisner H., Czech M.P.;
RT   "Cloning and characterization of a cDNA encoding the beta subunit of
RT   human casein kinase II.";
RL   Biochemistry 28:9053-9058(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1856204;
RA   Voss A., Wirkner U., Jacobi R., Hewitt N., Schwager C., Zimmermann J.,
RA   Ansorge W., Pyerin W.;
RT   "Structure of the gene encoding human casein kinase II subunit beta.";
RL   J. Biol. Chem. 266:13706-13711(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=12102635; DOI=10.1021/bi025791r;
RA   Singh L.S., Kalafatis M.;
RT   "Sequencing of full-length cDNA encoding the alpha and beta subunits
RT   of human casein kinase II from human platelets and megakaryocytic
RT   cells. Expression of the casein kinase IIalpha intronless gene in a
RT   megakaryocytic cell line.";
RL   Biochemistry 41:8935-8940(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14656967; DOI=10.1101/gr.1736803;
RA   Xie T., Rowen L., Aguado B., Ahearn M.E., Madan A., Qin S.,
RA   Campbell R.D., Hood L.;
RT   "Analysis of the gene-dense major histocompatibility complex class III
RT   region and its comparison to mouse.";
RL   Genome Res. 13:2621-2636(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Shiina S., Tamiya G., Oka A., Inoko H.;
RT   "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (DEC-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PHOSPHORYLATION.
RX   PubMed=2300566; DOI=10.1073/pnas.87.2.821;
RA   Ackerman P., Glover C.V., Osheroff N.;
RT   "Stimulation of casein kinase II by epidermal growth factor:
RT   relationship between the physiological activity of the kinase and the
RT   phosphorylation state of its beta subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:821-825(1990).
RN   [15]
RP   INTERACTION WITH CD163.
RX   PubMed=11298324;
RX   DOI=10.1002/1521-4141(200104)31:4<999::AID-IMMU999>3.0.CO;2-R;
RA   Ritter M., Buechler C., Kapinsky M., Schmitz G.;
RT   "Interaction of CD163 with the regulatory subunit of casein kinase II
RT   (CKII) and dependence of CD163 signaling on CKII and protein kinase
RT   C.";
RL   Eur. J. Immunol. 31:999-1009(2001).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=11239457; DOI=10.1016/S1097-2765(01)00176-9;
RA   Keller D.M., Zeng X., Wang Y., Zhang Q.H., Kapoor M., Shu H.,
RA   Goodman R., Lozano G., Zhao Y., Lu H.;
RT   "A DNA damage-induced p53 serine 392 kinase complex contains CK2,
RT   hSpt16, and SSRP1.";
RL   Mol. Cell 7:283-292(2001).
RN   [17]
RP   INTERACTION WITH FGF1.
RX   PubMed=11964394; DOI=10.1074/jbc.M112193200;
RA   Skjerpen C.S., Wesche J., Olsnes S.;
RT   "Identification of ribosome-binding protein p34 as an intracellular
RT   protein that binds acidic fibroblast growth factor.";
RL   J. Biol. Chem. 277:23864-23871(2002).
RN   [18]
RP   INTERACTION WITH SSRP1 AND SUPT16H.
RX   PubMed=12393879; DOI=10.1074/jbc.M209820200;
RA   Keller D.M., Lu H.;
RT   "p53 serine 392 phosphorylation increases after UV through induction
RT   of the assembly of the CK2.hSPT16.SSRP1 complex.";
RL   J. Biol. Chem. 277:50206-50213(2002).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF MUSK, AND INTERACTION WITH MUSK.
RX   PubMed=16818610; DOI=10.1101/gad.375206;
RA   Cheusova T., Khan M.A., Schubert S.W., Gavin A.C., Buchou T.,
RA   Jacob G., Sticht H., Allende J., Boldyreff B., Brenner H.R.,
RA   Hashemolhosseini S.;
RT   "Casein kinase 2-dependent serine phosphorylation of MuSK regulates
RT   acetylcholine receptor aggregation at the neuromuscular junction.";
RL   Genes Dev. 20:1800-1816(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-69 AND SER-209,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-209, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-212, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-209, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-209, CLEAVAGE OF INITIATOR METHIONINE [LARGE
RP   SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND SER-209, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-212, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.74 ANGSTROMS) OF 1-182, SUBUNIT, AND
RP   ZINC-BINDING SITES.
RX   PubMed=10357806; DOI=10.1093/emboj/18.11.2930;
RA   Chantalat L., Leroy D., Filhol O., Nueda A., Benitez M.J.,
RA   Chambaz E.M., Cochet C., Dideberg O.;
RT   "Crystal structure of the human protein kinase CK2 regulatory subunit
RT   reveals its zinc finger-mediated dimerization.";
RL   EMBO J. 18:2930-2940(1999).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEX WITH CSNK2A1,
RP   ZINC-BINDING SITES, SUBUNIT, AND PHOSPHORYLATION AT SER-2 AND SER-3.
RX   PubMed=11574463; DOI=10.1093/emboj/20.19.5320;
RA   Niefind K., Guerra B., Ermakowa I., Issinger O.G.;
RT   "Crystal structure of human protein kinase CK2: insights into basic
RT   properties of the CK2 holoenzyme.";
RL   EMBO J. 20:5320-5331(2001).
CC   -!- FUNCTION: Participates in Wnt signaling (By similarity). Plays a
CC       complex role in regulating the basal catalytic activity of the
CC       alpha subunit. {ECO:0000250, ECO:0000269|PubMed:11239457,
CC       ECO:0000269|PubMed:16818610}.
CC   -!- SUBUNIT: Tetramer composed of an alpha subunit, an alpha' subunit
CC       and two beta subunits. The beta subunit dimerization is mediated
CC       by zinc ions. Interacts with TCTEX1D3 (By similarity). Interacts
CC       with CD163. Also component of a CK2-SPT16-SSRP1 complex composed
CC       of SSRP1, SUPT16H, CSNK2A1, CSNK2A2 and CSNK2B, the complex
CC       associating following UV irradiation. Interacts with MUSK;
CC       mediates phosphorylation of MUSK by CK2. Interacts with FGF1; this
CC       interaction is increased in the presence of FIBP, suggesting a
CC       possible cooperative interaction between CSNKB and FIBP in binding
CC       to FGF1. {ECO:0000250, ECO:0000269|PubMed:10357806,
CC       ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:11298324,
CC       ECO:0000269|PubMed:11574463, ECO:0000269|PubMed:11964394,
CC       ECO:0000269|PubMed:12393879, ECO:0000269|PubMed:16818610}.
CC   -!- INTERACTION:
CC       Self; NbExp=7; IntAct=EBI-348169, EBI-348169;
CC       O00555:CACNA1A; NbExp=2; IntAct=EBI-348169, EBI-766279;
CC       O00257-3:CBX4; NbExp=2; IntAct=EBI-348169, EBI-4392727;
CC       Q9JK25:Clip1 (xeno); NbExp=2; IntAct=EBI-348169, EBI-908338;
CC       O08785:Clock (xeno); NbExp=2; IntAct=EBI-348169, EBI-79859;
CC       P68400:CSNK2A1; NbExp=17; IntAct=EBI-348169, EBI-347804;
CC       P19784:CSNK2A2; NbExp=8; IntAct=EBI-348169, EBI-347451;
CC       Q6VY07:PACS1; NbExp=3; IntAct=EBI-348169, EBI-2555014;
CC       Q99496:RNF2; NbExp=2; IntAct=EBI-348169, EBI-722416;
CC       Q96EB6:SIRT1; NbExp=5; IntAct=EBI-348169, EBI-1802965;
CC   -!- PTM: Phosphorylated by alpha subunit.
CC       {ECO:0000269|PubMed:11574463, ECO:0000269|PubMed:2300566}.
CC   -!- SIMILARITY: Belongs to the casein kinase 2 subunit beta family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI18393.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X16937; CAA34811.1; -; mRNA.
DR   EMBL; X16312; CAA34379.1; -; mRNA.
DR   EMBL; M30448; AAA52123.1; -; mRNA.
DR   EMBL; X57152; CAA40442.1; -; Genomic_DNA.
DR   EMBL; AY113186; AAM50092.1; -; mRNA.
DR   EMBL; CR541699; CAG46500.1; -; mRNA.
DR   EMBL; AF129756; AAD18081.1; -; Genomic_DNA.
DR   EMBL; BA000025; BAB63386.1; -; Genomic_DNA.
DR   EMBL; DQ314868; ABC40727.1; -; Genomic_DNA.
DR   EMBL; AK311860; BAG34801.1; -; mRNA.
DR   EMBL; AL662899; CAI96141.1; -; Genomic_DNA.
DR   EMBL; AL662899; CAI18393.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AL670886; CAI17800.1; -; Genomic_DNA.
DR   EMBL; AL805934; CAI18523.1; -; Genomic_DNA.
DR   EMBL; BX511262; CAM45825.1; -; Genomic_DNA.
DR   EMBL; CR753842; CAQ06572.1; -; Genomic_DNA.
DR   EMBL; CR354443; CAQ07002.1; -; Genomic_DNA.
DR   EMBL; CR759761; CAQ10879.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03473.1; -; Genomic_DNA.
DR   EMBL; BC112017; AAI12018.1; -; mRNA.
DR   EMBL; BC112019; AAI12020.1; -; mRNA.
DR   CCDS; CCDS4712.1; -.
DR   PIR; A39459; A39459.
DR   RefSeq; NP_001269314.1; NM_001282385.1.
DR   RefSeq; NP_001311.3; NM_001320.6.
DR   UniGene; Hs.73527; -.
DR   PDB; 1DS5; X-ray; 3.16 A; E/F/G/H=181-203.
DR   PDB; 1JWH; X-ray; 3.10 A; C/D=1-215.
DR   PDB; 1QF8; X-ray; 1.74 A; A/B=1-182.
DR   PDB; 3EED; X-ray; 2.80 A; A/B=1-193.
DR   PDB; 4DGL; X-ray; 3.00 A; A/B=1-215.
DR   PDB; 4MD7; X-ray; 3.10 A; A/B/C/D=1-215.
DR   PDB; 4MD8; X-ray; 3.30 A; A/B/C/D=1-215.
DR   PDB; 4MD9; X-ray; 3.50 A; A/B/C/D/I/J/N/O=1-215.
DR   PDB; 4NH1; X-ray; 3.30 A; C/D=1-215.
DR   PDBsum; 1DS5; -.
DR   PDBsum; 1JWH; -.
DR   PDBsum; 1QF8; -.
DR   PDBsum; 3EED; -.
DR   PDBsum; 4DGL; -.
DR   PDBsum; 4MD7; -.
DR   PDBsum; 4MD8; -.
DR   PDBsum; 4MD9; -.
DR   PDBsum; 4NH1; -.
DR   ProteinModelPortal; P67870; -.
DR   SMR; P67870; -.
DR   BioGrid; 107843; 266.
DR   DIP; DIP-131N; -.
DR   IntAct; P67870; 197.
DR   MINT; MINT-88683; -.
DR   STRING; 9606.ENSP00000365025; -.
DR   ChEMBL; CHEMBL2358; -.
DR   iPTMnet; P67870; -.
DR   PhosphoSitePlus; P67870; -.
DR   DMDM; 54037520; -.
DR   EPD; P67870; -.
DR   MaxQB; P67870; -.
DR   PaxDb; P67870; -.
DR   PeptideAtlas; P67870; -.
DR   PRIDE; P67870; -.
DR   DNASU; 1460; -.
DR   Ensembl; ENST00000375865; ENSP00000365025; ENSG00000204435.
DR   Ensembl; ENST00000375866; ENSP00000365026; ENSG00000204435.
DR   Ensembl; ENST00000375882; ENSP00000365042; ENSG00000204435.
DR   Ensembl; ENST00000383427; ENSP00000372919; ENSG00000206406.
DR   Ensembl; ENST00000383433; ENSP00000372925; ENSG00000206406.
DR   Ensembl; ENST00000400110; ENSP00000382980; ENSG00000206406.
DR   Ensembl; ENST00000412802; ENSP00000413469; ENSG00000224774.
DR   Ensembl; ENST00000418230; ENSP00000411322; ENSG00000228875.
DR   Ensembl; ENST00000422567; ENSP00000407018; ENSG00000224398.
DR   Ensembl; ENST00000429633; ENSP00000409510; ENSG00000230700.
DR   Ensembl; ENST00000431476; ENSP00000394855; ENSG00000224398.
DR   Ensembl; ENST00000436169; ENSP00000412520; ENSG00000224398.
DR   Ensembl; ENST00000443673; ENSP00000400188; ENSG00000230700.
DR   Ensembl; ENST00000448596; ENSP00000391038; ENSG00000232960.
DR   Ensembl; ENST00000451917; ENSP00000415303; ENSG00000224774.
DR   Ensembl; ENST00000452985; ENSP00000415237; ENSG00000228875.
DR   Ensembl; ENST00000453234; ENSP00000395275; ENSG00000224774.
DR   Ensembl; ENST00000454382; ENSP00000390900; ENSG00000232960.
DR   Ensembl; ENST00000454511; ENSP00000393756; ENSG00000232960.
DR   Ensembl; ENST00000455161; ENSP00000407379; ENSG00000230700.
DR   Ensembl; ENST00000458330; ENSP00000410802; ENSG00000228875.
DR   GeneID; 1460; -.
DR   KEGG; hsa:1460; -.
DR   UCSC; uc003nvr.3; human.
DR   CTD; 1460; -.
DR   DisGeNET; 1460; -.
DR   GeneCards; CSNK2B; -.
DR   HGNC; HGNC:2460; CSNK2B.
DR   HPA; CAB004349; -.
DR   HPA; CAB013087; -.
DR   HPA; CAB016059; -.
DR   HPA; HPA005944; -.
DR   MIM; 115441; gene.
DR   neXtProt; NX_P67870; -.
DR   OpenTargets; ENSG00000204435; -.
DR   PharmGKB; PA26960; -.
DR   eggNOG; KOG3092; Eukaryota.
DR   eggNOG; COG5041; LUCA.
DR   GeneTree; ENSGT00390000003781; -.
DR   HOGENOM; HOG000039270; -.
DR   HOVERGEN; HBG051131; -.
DR   InParanoid; P67870; -.
DR   KO; K03115; -.
DR   PhylomeDB; P67870; -.
DR   TreeFam; TF314462; -.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-201688; WNT mediated activation of DVL.
DR   Reactome; R-HSA-2514853; Condensation of Prometaphase Chromosomes.
DR   Reactome; R-HSA-445144; Signal transduction by L1.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SignaLink; P67870; -.
DR   SIGNOR; P67870; -.
DR   EvolutionaryTrace; P67870; -.
DR   GeneWiki; CSNK2B; -.
DR   GenomeRNAi; 1460; -.
DR   PRO; PR:P67870; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000204435; -.
DR   CleanEx; HS_CSNK2B; -.
DR   ExpressionAtlas; P67870; baseline and differential.
DR   Genevisible; P67870; HS.
DR   GO; GO:0000785; C:chromatin; IEA:Ensembl.
DR   GO; GO:0005929; C:cilium; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016363; C:nuclear matrix; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0005956; C:protein kinase CK2 complex; IDA:CAFA.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0019887; F:protein kinase regulator activity; NAS:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:CAFA.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IEA:Ensembl.
DR   GO; GO:0008134; F:transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0033211; P:adiponectin-activated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0043623; P:cellular protein complex assembly; NAS:BHF-UCL.
DR   GO; GO:0061154; P:endothelial tube morphogenesis; IMP:BHF-UCL.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:BHF-UCL.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:CAFA.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0032927; P:positive regulation of activin receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; TAS:Reactome.
DR   GO; GO:0051101; P:regulation of DNA binding; NAS:BHF-UCL.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0033574; P:response to testosterone; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.1820.10; -; 1.
DR   InterPro; IPR016149; Casein_kin_II_reg-sub_a-hlx.
DR   InterPro; IPR000704; Casein_kinase_II_reg-sub.
DR   PANTHER; PTHR11740; PTHR11740; 1.
DR   Pfam; PF01214; CK_II_beta; 1.
DR   PRINTS; PR00472; CASNKINASEII.
DR   SMART; SM01085; CK_II_beta; 1.
DR   SUPFAM; SSF57798; SSF57798; 1.
DR   PROSITE; PS01101; CK2_BETA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Isopeptide bond;
KW   Metal-binding; Phosphoprotein; Reference proteome; Ubl conjugation;
KW   Wnt signaling pathway; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   CHAIN         2    215       Casein kinase II subunit beta.
FT                                /FTId=PRO_0000068236.
FT   REGION      188    193       Interaction with alpha subunit.
FT                                {ECO:0000250}.
FT   COMPBIAS     55     64       Asp/Glu-rich (acidic).
FT   METAL       109    109       Zinc.
FT   METAL       114    114       Zinc.
FT   METAL       137    137       Zinc.
FT   METAL       140    140       Zinc.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES       2      2       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11574463}.
FT   MOD_RES       3      3       Phosphoserine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11574463}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES      37     37       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      69     69       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     209    209       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     212    212       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   CROSSLNK    212    212       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25755297}.
FT   CONFLICT    194    194       P -> A (in Ref. 3; AAA52123).
FT                                {ECO:0000305}.
FT   HELIX         9     15       {ECO:0000244|PDB:1QF8}.
FT   TURN         17     20       {ECO:0000244|PDB:1JWH}.
FT   HELIX        27     31       {ECO:0000244|PDB:1QF8}.
FT   HELIX        33     36       {ECO:0000244|PDB:1QF8}.
FT   HELIX        39     41       {ECO:0000244|PDB:1QF8}.
FT   STRAND       43     45       {ECO:0000244|PDB:4DGL}.
FT   HELIX        46     53       {ECO:0000244|PDB:1QF8}.
FT   STRAND       59     61       {ECO:0000244|PDB:4NH1}.
FT   HELIX        67     87       {ECO:0000244|PDB:1QF8}.
FT   HELIX        91    102       {ECO:0000244|PDB:1QF8}.
FT   TURN        103    106       {ECO:0000244|PDB:1QF8}.
FT   HELIX       112    114       {ECO:0000244|PDB:1QF8}.
FT   STRAND      120    122       {ECO:0000244|PDB:1QF8}.
FT   STRAND      134    136       {ECO:0000244|PDB:1QF8}.
FT   TURN        138    140       {ECO:0000244|PDB:1QF8}.
FT   STRAND      142    144       {ECO:0000244|PDB:3EED}.
FT   HELIX       149    151       {ECO:0000244|PDB:1QF8}.
FT   STRAND      152    155       {ECO:0000244|PDB:4MD7}.
FT   HELIX       156    158       {ECO:0000244|PDB:1QF8}.
FT   TURN        159    162       {ECO:0000244|PDB:4DGL}.
FT   HELIX       163    170       {ECO:0000244|PDB:1QF8}.
FT   HELIX       172    174       {ECO:0000244|PDB:1QF8}.
FT   STRAND      187    189       {ECO:0000244|PDB:4MD9}.
FT   STRAND      190    192       {ECO:0000244|PDB:4DGL}.
FT   HELIX       195    198       {ECO:0000244|PDB:4DGL}.
FT   TURN        199    201       {ECO:0000244|PDB:4DGL}.
FT   HELIX       202    205       {ECO:0000244|PDB:4DGL}.
SQ   SEQUENCE   215 AA;  24942 MW;  E465B1E699B0E0EC CRC64;
     MSSSEEVSWI SWFCGLRGNE FFCEVDEDYI QDKFNLTGLN EQVPHYRQAL DMILDLEPDE
     ELEDNPNQSD LIEQAAEMLY GLIHARYILT NRGIAQMLEK YQQGDFGYCP RVYCENQPML
     PIGLSDIPGE AMVKLYCPKC MDVYTPKSSR HHHTDGAYFG TGFPHMLFMV HPEYRPKRPA
     NQFVPRLYGF KIHPMAYQLQ LQAASNFKSP VKTIR
//
